BGIM
CVS icon

Boussard & Gavaudan Investment Management’s CVS Health CVS Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,325
Closed -$227K – 29
2014
Q4 		$227K Sell
2,325
-911
-28% -$80.3K 0.15% 18
2014
Q3 		$259K Buy
+3,236
New +$255K 0.15% 43

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boussard & Gavaudan Investment Management's CVS Position: Q1 2015 in Review

Boussard & Gavaudan Investment Management sold out of CVS Health (CVS) in Q1 2015, closing a stake of 2,325 shares — an estimated $227K sold.

Boussard & Gavaudan Investment Management first reported a position in CVS in Q3 2014 and held it in 2 quarters. The position peaked at $259K in Q3 2014. 1,460 funds tracked by Wall St. Rank hold CVS as of Q1 2015.

  • Boussard & Gavaudan Investment Management reported no remaining CVS Health position as of Q1 2015 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 2,325 CVS Health shares in Q1 2015, an estimated $227K.
  • Boussard & Gavaudan Investment Management first reported a position in CVS Health in Q3 2014 and held it in 2 quarters.
  • Boussard & Gavaudan Investment Management's CVS Health position peaked at $259K in Q3 2014.
  • 1,460 funds tracked by Wall St. Rank held CVS Health as of Q1 2015.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2015, filed 12 May 2015.